Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
238K
-
Shares change
-
+180K
-
Total reported value, excl. options
-
$67K
-
Value change
-
+$50.5K
-
Number of buys
-
4
-
Price
-
$0.28
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q4 2016
5 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q4 2016.
IGC Pharma, Inc. - COM NEW (IGC) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 238K shares
.
Largest 7 shareholders include Creative Planning (65K shares), PANAGORA ASSET MANAGEMENT INC (49.2K shares), CITADEL ADVISORS LLC (47.2K shares), KCG HOLDINGS, INC. (41.8K shares), UBS Group AG (34.3K shares), Gradient Investments LLC (2K shares), and LADENBURG THALMANN FINANCIAL SERVICES INC. (0 shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.